1. Horne BD, Joy EA, Hofmann MG, Gesteland PH, Cannon JB, Lefler JS, et al. Short-Term Elevation of Fine Particulate Matter Air Pollution and Acute Lower Respiratory Infection. Am J Respir Crit Care Med. 2018;198 6:759-66; doi: 10.1164/rccm.201709-1883OC.
2. Lelieveld J, Evans JS, Fnais M, Giannadaki D, Pozzer A. The contribution of outdoor air pollution sources to premature mortality on a global scale. Nature. 2015;525 7569:367-71; doi: 10.1038/nature15371.
3. Wuyts WA, Agostini C, Antoniou KM, Bouros D, Chambers RC, Cottin V, et al. The pathogenesis of pulmonary fibrosis: a moving target. Eur Respir J. 2013;41 5:1207-18; doi: 10.1183/09031936.00073012.
4. Nair GB, Matela A, Kurbanov D, Raghu G. Newer developments in idiopathic pulmonary fibrosis in the era of anti-fibrotic medications. Expert Rev Respir Med. 2016;10 6:699-711; doi: 10.1080/17476348.2016.1177461.
5. Zhang Z, Qu J, Zheng C, Zhang P, Zhou W, Cui W, et al. Nrf2 antioxidant pathway suppresses Numb-mediated epithelial-mesenchymal transition during pulmonary fibrosis. Cell Death Dis. 2018;9 2:83; doi: 10.1038/s41419-017-0198-x.
6. Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG, Brumwell AN, et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci U S A. 2006;103 35:13180-5; doi: 10.1073/pnas.0605669103.
7. Zheng R, Tao L, Jian H, Chang Y, Cheng Y, Feng Y, et al. NLRP3 inflammasome activation and lung fibrosis caused by airborne fine particulate matter. Ecotoxicol Environ Saf. 2018;163:612-9; doi: 10.1016/j.ecoenv.2018.07.076.
8. Wang L, Xu J, Liu H, Li J, Hao H. PM2.5 inhibits SOD1 expression by up-regulating microRNA-206 and promotes ROS accumulation and disease progression in asthmatic mice. Int Immunopharmacol. 2019;76:105871; doi: 10.1016/j.intimp.2019.105871.
9. Valavanidis A, Vlachogianni T, Fiotakis K, Loridas S. Pulmonary oxidative stress, inflammation and cancer: respirable particulate matter, fibrous dusts and ozone as major causes of lung carcinogenesis through reactive oxygen species mechanisms. Int J Environ Res Public Health. 2013;10 9:3886-907; doi: 10.3390/ijerph10093886.
10. Borcherding DC, Siefert ME, Lin S, Brewington J, Sadek H, Clancy JP, et al. Clinically-approved CFTR modulators rescue Nrf2 dysfunction in cystic fibrosis airway epithelia. J Clin Invest. 2019;129 8:3448-63; doi: 10.1172/jci96273.
11. Zheng Y, Fan J, Chen HW, Liu EQ. Trametes orientalis polysaccharide alleviates PM(2.5)-induced lung injury in mice through its antioxidant and anti-inflammatory activities. Food Funct. 2019;10 12:8005-15; doi: 10.1039/c9fo01777a.
12. Zhou W, Mo X, Cui W, Zhang Z, Li D, Li L, et al. Nrf2 inhibits epithelial-mesenchymal transition by suppressing snail expression during pulmonary fibrosis. Sci Rep. 2016;6:38646; doi: 10.1038/srep38646.
13. Cayir A, Barrow TM, Guo L, Byun HM. Exposure to environmental toxicants reduces global N6-methyladenosine RNA methylation and alters expression of RNA methylation modulator genes. Environ Res. 2019;175:228-34; doi: 10.1016/j.envres.2019.05.011.
14. Han B, Chu C, Su X, Zhang N, Zhou L, Zhang M, et al. N(6)-methyladenosine-dependent primary microRNA-126 processing activated PI3K-AKT-mTOR pathway drove the development of pulmonary fibrosis induced by nanoscale carbon black particles in rats. Nanotoxicology. 2020;14 1:1-20; doi: 10.1080/17435390.2019.1661041.
15. Wang J, Ishfaq M, Xu L, Xia C, Chen C, Li J. METTL3/m(6)A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway. Front Pharmacol. 2019;10:517; doi: 10.3389/fphar.2019.00517.
16. Zhong X, Yu J, Frazier K, Weng X, Li Y, Cham CM, et al. Circadian Clock Regulation of Hepatic Lipid Metabolism by Modulation of m(6)A mRNA Methylation. Cell Rep. 2018;25 7:1816-28.e4; doi: 10.1016/j.celrep.2018.10.068.
17. Yang F, Jin H, Que B, Chao Y, Zhang H, Ying X, et al. Dynamic m(6)A mRNA methylation reveals the role of METTL3-m(6)A-CDCP1 signaling axis in chemical carcinogenesis. Oncogene. 2019;38 24:4755-72; doi: 10.1038/s41388-019-0755-0.
18. Zhao TX, Wang JK, Shen LJ, Long CL, Liu B, Wei Y, et al. Increased m6A RNA modification is related to the inhibition of the Nrf2-mediated antioxidant response in di-(2-ethylhexyl) phthalate-induced prepubertal testicular injury. Environ Pollut. 2020;259:113911; doi: 10.1016/j.envpol.2020.113911.
19. Su X, Tian J, Li B, Zhou L, Kang H, Pei Z, et al. Ambient PM2.5 caused cardiac dysfunction through FoxO1-targeted cardiac hypertrophy and macrophage-activated fibrosis in mice. Chemosphere. 2020;247:125881; doi: 10.1016/j.chemosphere.2020.125881.
20. Li D, Zhang R, Cui L, Chu C, Zhang H, Sun H, et al. Multiple organ injury in male C57BL/6J mice exposed to ambient particulate matter in a real-ambient PM exposure system in Shijiazhuang, China. Environ Pollut. 2019;248:874-87; doi: 10.1016/j.envpol.2019.02.097.
21. Zhang R, Niu Y, Li Y, Zhao C, Song B, Li Y, et al. Acute toxicity study of the interaction between titanium dioxide nanoparticles and lead acetate in mice. Environ Toxicol Pharmacol. 2010;30 1:52-60; doi: 10.1016/j.etap.2010.03.015.
22. Jin H, Ying X, Que B, Wang X, Chao Y, Zhang H, et al. N(6)-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer. EBioMedicine. 2019;47:195-207; doi: 10.1016/j.ebiom.2019.07.068.
23. Dominissini D, Moshitch-Moshkovitz S, Salmon-Divon M, Amariglio N, Rechavi G. Transcriptome-wide mapping of N(6)-methyladenosine by m(6)A-seq based on immunocapturing and massively parallel sequencing. Nat Protoc. 2013;8 1:176-89; doi: 10.1038/nprot.2012.148.
24. Somasekharan SP, Stoynov N, Rotblat B, Leprivier G, Galpin JD, Ahern CA, et al. Identification and quantification of newly synthesized proteins translationally regulated by YB-1 using a novel Click-SILAC approach. J Proteomics. 2012;77:e1-10; doi: 10.1016/j.jprot.2012.08.019.
25. Zhang Z, Chen LQ, Zhao YL, Yang CG, Roundtree IA, Zhang Z, et al. Single-base mapping of m(6)A by an antibody-independent method. Sci Adv. 2019;5 7:eaax0250; doi: 10.1126/sciadv.aax0250.
26. Ying X, Jiang X, Zhang H, Liu B, Huang Y, Zhu X, et al. Programmable N6-methyladenosine modification of CDCP1 mRNA by RCas9-methyltransferase like 3 conjugates promotes bladder cancer development. Mol Cancer. 2020;19 1:169; doi: 10.1186/s12943-020-01289-0.
27. Li Z, Li N, Guo C, Li X, Qian Y, Yang Y, et al. The global DNA and RNA methylation and their reversal in lung under different concentration exposure of ambient air particulate matter in mice. Ecotoxicol Environ Saf. 2019;172:396-402; doi: 10.1016/j.ecoenv.2019.01.111.
28. Zhou L, Li P, Zhang M, Han B, Chu C, Su X, et al. Carbon black nanoparticles induce pulmonary fibrosis through NLRP3 inflammasome pathway modulated by miR-96 targeted FOXO3a. Chemosphere. 2020;241:125075; doi: 10.1016/j.chemosphere.2019.125075.
29. Balli D, Ustiyan V, Zhang Y, Wang IC, Masino AJ, Ren X, et al. Foxm1 transcription factor is required for lung fibrosis and epithelial-to-mesenchymal transition. Embo j. 2013;32 2:231-44; doi: 10.1038/emboj.2012.336.
30. Liu MH, Lin AH, Ko HK, Perng DW, Lee TS, Kou YR. Prevention of Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice by Paeonol. Front Physiol. 2017;8:193; doi: 10.3389/fphys.2017.00193.
31. Xu Z, Li Z, Liao Z, Gao S, Hua L, Ye X, et al. PM(2.5) induced pulmonary fibrosis in vivo and in vitro. Ecotoxicol Environ Saf. 2019;171:112-21; doi: 10.1016/j.ecoenv.2018.12.061.
32. Deng X, Rui W, Zhang F, Ding W. PM2.5 induces Nrf2-mediated defense mechanisms against oxidative stress by activating PIK3/AKT signaling pathway in human lung alveolar epithelial A549 cells. Cell Biol Toxicol. 2013;29 3:143-57; doi: 10.1007/s10565-013-9242-5.
33. Liu S, Zhang W, Zhang F, Roepstorff P, Yang F, Lu Z, et al. TMT-Based Quantitative Proteomics Analysis Reveals Airborne PM(2.5)-Induced Pulmonary Fibrosis. Int J Environ Res Public Health. 2018;16 1; doi: 10.3390/ijerph16010098.
34. Wang E. Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved. Cancer Res. 1995;55 11:2284-92.
35. Xu MX, Zhu YF, Chang HF, Liang Y. Nanoceria restrains PM2.5-induced metabolic disorder and hypothalamus inflammation by inhibition of astrocytes activation related NF-κB pathway in Nrf2 deficient mice. Free Radic Biol Med. 2016;99:259-72; doi: 10.1016/j.freeradbiomed.2016.08.021.
36. Zhang H, Xue L, Li B, Tian H, Zhang Z, Tao S. Therapeutic potential of bixin in PM2.5 particles-induced lung injury in an Nrf2-dependent manner. Free Radic Biol Med. 2018;126:166-76; doi: 10.1016/j.freeradbiomed.2018.08.015.
37. Mohammad J, Singh RR, Riggle C, Haugrud B, Abdalla MY, Reindl KM. JNK inhibition blocks piperlongumine-induced cell death and transcriptional activation of heme oxygenase-1 in pancreatic cancer cells. Apoptosis. 2019;24 9-10:730-44; doi: 10.1007/s10495-019-01553-9.
38. Qu J, Zhang Z, Zhang P, Zheng C, Zhou W, Cui W, et al. Downregulation of HMGB1 is required for the protective role of Nrf2 in EMT-mediated PF. J Cell Physiol. 2019;234 6:8862-72; doi: 10.1002/jcp.27548.
39. Chu C, Zhang H, Cui S, Han B, Zhou L, Zhang N, et al. Ambient PM2.5 caused depressive-like responses through Nrf2/NLRP3 signaling pathway modulating inflammation. J Hazard Mater. 2019;369:180-90; doi: 10.1016/j.jhazmat.2019.02.026.
40. Ryter SW, Choi AM. Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation. Transl Res. 2016;167 1:7-34; doi: 10.1016/j.trsl.2015.06.011.
41. Fizeșan I, Chary A, Cambier S, Moschini E, Serchi T, Nelissen I, et al. Responsiveness assessment of a 3D tetra-culture alveolar model exposed to diesel exhaust particulate matter. Toxicol In Vitro. 2018;53:67-79; doi: 10.1016/j.tiv.2018.07.019.
42. Dong W, Yang B, Wang L, Li B, Guo X, Zhang M, et al. Curcumin plays neuroprotective roles against traumatic brain injury partly via Nrf2 signaling. Toxicol Appl Pharmacol. 2018;346:28-36; doi: 10.1016/j.taap.2018.03.020.
43. Oh CJ, Kim JY, Min AK, Park KG, Harris RA, Kim HJ, et al. Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling. Free Radic Biol Med. 2012;52 3:671-82; doi: 10.1016/j.freeradbiomed.2011.11.012.
44. Liu J, Harada BT, He C. Regulation of Gene Expression by N(6)-methyladenosine in Cancer. Trends Cell Biol. 2019;29 6:487-99; doi: 10.1016/j.tcb.2019.02.008.
45. Deng X, Su R, Weng H, Huang H, Li Z, Chen J. RNA N(6)-methyladenosine modification in cancers: current status and perspectives. Cell Res. 2018;28 5:507-17; doi: 10.1038/s41422-018-0034-6.
46. Wilson C, Chen PJ, Miao Z, Liu DR. Programmable m(6)A modification of cellular RNAs with a Cas13-directed methyltransferase. Nat Biotechnol. 2020; doi: 10.1038/s41587-020-0572-6.